Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Is there a Relation between Depression and Anxiety to Clinical Characteristics among Patients with T2D in Greece?

Author(s): Paraskevi Theofilou*

Volume 20, Issue 3, 2024

Published on: 25 July, 2023

Article ID: e060723218470 Pages: 8

DOI: 10.2174/1573399820666230706124718

Price: $65

conference banner
Abstract

Background: Diabetes is a chronic disease that may be related to various periods of an individual’s life.

Aim: The aim of the present study is the investigation of the existence of depression and anxiety among patients suffering from type 2 diabetes as well as the factors that influence these variables (depression and anxiety).

Materials and Methods: The Hospital Anxiety and Depression Scale (HADS) for mental health assessment was used in the context of the collection of the research data. The study involved 100 patients (42 men and 58 women) with an average age of 63.72 ± 9.84 years of life.

Result: The results showed that there was a positive correlation between HbA1c value and anxiety as well as HADS questionnaire total score, and a positive correlation between blood glucose value and anxiety as well as HADS questionnaire total score.

Conclusion: Both depression and anxiety of these patients are influenced by different clinical factors.

[1]
Kontoangelos , et al. Diabetes mellitus and psychopathology. Archives of Hellenic Medicine/Arheia Ellenikes Iatrikes 2013; 30(6): 688-99.
[2]
Roy T, Lloyd CE. Epidemiology of depression and diabetes: A systematic review. J Affect Disord 2012; 142 (Suppl.): S8-S21.
[http://dx.doi.org/10.1016/S0165-0327(12)70004-6] [PMID: 23062861]
[3]
Anxiety Disorders. Sane Australia. 2011. Available From: https://www.sane.org/news/tag/anxiety
[4]
Schoevers RA, Van HL, Koppelmans V, Kool S, Dekker JJ. Managing the patient with co-morbid depression and an anxiety disorder. Drugs 2008; 68(12): 1621-34.
[http://dx.doi.org/10.2165/00003495-200868120-00002] [PMID: 18681487]
[5]
Hopkins D, Lawrence I, Mansell P, et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: The U.K. DAFNE experience. Diabetes Care 2012; 35(8): 1638-42.
[http://dx.doi.org/10.2337/dc11-1579] [PMID: 22619082]
[6]
de Ornelas Maia ACC, Braga AA, Brouwers A, Nardi AE. de Oliveira e Silva AC. Prevalence of psychiatric disorders in patients with diabetes types 1 and 2. Compr Psychiatry 2012; 53(8): 1169-73.
[http://dx.doi.org/10.1016/j.comppsych.2012.03.011] [PMID: 22521330]
[7]
Speight J, Browne JL, Holmes-Truscott E, Hendrieckx C, Pouwer F. Diabetes MILES-Australia (management and impact for long-term empowerment and success): Methods and sample characteristics of a national survey of the psychological aspects of living with type 1 or type 2 diabetes in Australian adults. BMC Public Health 2012; 12(1): 120.
[http://dx.doi.org/10.1186/1471-2458-12-120] [PMID: 22325032]
[8]
Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med 2009; 26(2): 153-61.
[http://dx.doi.org/10.1111/j.1464-5491.2008.02648.x] [PMID: 19236618]
[9]
Tacconelli E. Systematic reviews: CRD’s guidance for undertaking reviews in health care. Lancet Infect Dis 2010; 10(4): 226.
[http://dx.doi.org/10.1016/S1473-3099(10)70065-7]
[10]
Hirai FE, Tielsch JM, Klein BEK, Klein R. Relationship between retinopathy severity, visual impairment and depression in persons with long-term type 1 diabetes. Ophthalmic Epidemiol 2012; 19(4): 196-203.
[http://dx.doi.org/10.3109/09286586.2012.692006] [PMID: 22775274]
[11]
Ahola AJ, Thorn LM, Saraheimo M, Forsblom C, Groop PH. Depression is associated with the metabolic syndrome among patients with type 1 diabetes. Ann Med 2010; 42(7): 495-501.
[http://dx.doi.org/10.3109/07853890.2010.503660] [PMID: 20653460]
[12]
Melin EO, Thunander M, Svensson R, Landin-Olsson M, Thulesius HO. Depression, obesity, and smoking were independently associated with inadequate glycemic control in patients with type 1 diabetes. Eur J Endocrinol 2013; 168(6): 861-9.
[http://dx.doi.org/10.1530/EJE-13-0137] [PMID: 23536618]
[13]
Gendelman N, Snell-Bergeon JK, McFann K, et al. Prevalence and correlates of depression in individuals with and without type 1 diabetes. Diabetes Care 2009; 32(4): 575-9.
[http://dx.doi.org/10.2337/dc08-1835] [PMID: 19171719]
[14]
Reichel A, et al. Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII). Mol Psychiatry 2005; 10(11): 975-6.
[http://dx.doi.org/10.1038/sj.mp.4001726] [PMID: 16077680]
[15]
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361-70.
[http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x]
[16]
Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. The hospital anxiety and depression scale in Greek cancer patients: Psychometric analyses and applicability. Support Care Cancer 2004; 12(12): 821-5.
[http://dx.doi.org/10.1007/s00520-004-0698-y] [PMID: 15480813]
[17]
Michopoulos I, Douzenis A, Kalkavoura C, et al. Hospital Anxiety and Depression Scale (HADS): Validation in a Greek general hospital sample. Ann Gen Psychiatry 2008; 7(1): 4.
[http://dx.doi.org/10.1186/1744-859X-7-4] [PMID: 18325093]
[18]
Papadopoulos A, Oikonomakis E, Kontodimopoulos N, Frydas A, Niakas D. Evaluation of the CYPZ of type II diabetic diseases. Arch Greek Med 2007; 24(1): 66-74.
[19]
Kontodimopoulos N, Pappa E, Chadjiapostolou Z, Arvanitaki E, Papadopoulos AA, Niakas D. Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications. Eur J Health Econ 2012; 13(1): 111-20.
[http://dx.doi.org/10.1007/s10198-010-0290-y] [PMID: 21132558]
[20]
Grandinetti A, Kaholokula JK, Crabbe KM, Kenui CK, Chen R, Chang HK. Relationship between depressive symptoms and diabetes among native Hawaiians. Psychoneuroendocrinology 2000; 25(3): 239-46.
[http://dx.doi.org/10.1016/S0306-4530(99)00047-5] [PMID: 10737695]
[21]
Kaholokula JK, Haynes SN, Grandinetti A, Chang HK. Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behav Med 2003; 26(5): 435-58.
[http://dx.doi.org/10.1023/A:1025772001665] [PMID: 14593852]
[22]
Park H, Hong Y, Lee H, Ha E, Sung Y. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol 2004; 57(9): 978-84.
[http://dx.doi.org/10.1016/j.jclinepi.2004.01.015] [PMID: 15504641]
[23]
Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010; 8(1): 18.
[http://dx.doi.org/10.1186/1477-7525-8-18] [PMID: 20132542]
[24]
Jaser SS, Patel N, Xu M, Tamborlane WV, Grey M. Stress and coping predicts adjustment and glycemic control in adolescents with type 1 diabetes. Ann Behav Med 2017; 51(1): 30-8.
[http://dx.doi.org/10.1007/s12160-016-9825-5] [PMID: 27496164]
[25]
Pérez-Fernández A, Fernández-Berrocal P, Gutiérrez-Cobo MJ. The relationship between well‐being and HbA1c in adults with type 1 diabetes: A systematic review. J Diabetes 2023; 15(2): 152-64.
[http://dx.doi.org/10.1111/1753-0407.13357] [PMID: 36796311]
[26]
Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004; 363(9421): 1589-97.
[http://dx.doi.org/10.1016/S0140-6736(04)16202-8] [PMID: 15145632]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy